Becker Hewes
About Becker Hewes
Becker Hewes' Title and Role
Becker Hewes serves as the Chief Medical Officer. In this role, Hewes is responsible for leading the medical and clinical strategies, overseeing clinical trials, and guiding the overall medical vision of the company.
Becker Hewes' Education and Expertise
Becker Hewes holds an M.D. from the Georgetown University School of Medicine, providing him with a robust foundation in medical education. He earned his undergraduate degree, a B.S., from Vanderbilt University. This combination of education has equipped Hewes with extensive knowledge and expertise necessary for his contributions in the fields of oncology and hematology.
Becker Hewes' Background in Oncology and Hematology
Becker Hewes has an extensive background in clinical development in oncology and hematology. His professional journey includes significant roles at renowned organizations such as AstraZeneca PLC, Genzyme Corporation, and Wyeth Pharmaceuticals, where he led critical projects in oncology and hematology.
Becker Hewes' Achievements at Novartis and Repertoire
At Novartis Institutes for BioMedical Research, Becker Hewes served as Executive Director of Translational Clinical Oncology from June 2013 to February 2017. During this time, he led clinical development efforts for early-stage oncology programs, including Kisqali (ribociclib). Later, as the Chief Medical Officer of Repertoire Immune Medicines from February 2017 to May 2020, Hewes continued to apply his expertise to advance immuno-oncology research.
Becker Hewes' Work in Pediatric Oncology
Becker Hewes has also contributed significantly to pediatric oncology through his work as a pediatric oncologist at Children's Healthcare of Atlanta. His clinical experience in treating young patients with cancer has been an integral part in shaping his medical career.